Back to Search
Start Over
[123I]Ioflupane SPECT in the assessment of Parkinson's disease in a patient with retinitis pigmentosa.
- Source :
- Nuclear Medicine Review; 2023, Vol. 26, p34-35, 2p
- Publication Year :
- 2023
-
Abstract
- Retinis pigmentosa is a form of retinal dystrophy characterized by pigment deposition resulting in loss of peripheral vision, tunnel vision, night blindness and in some cases full blindness. Parkinson's disease is a progressive extrapyramidal neurological disorder characterized by rigidity, bradykinesia and tremor at rest due to loss of substantia nigra's dopaminergic cell; this loss can be evaluated with [<superscript>123</superscript>I]Ioflupane single-photon emission computed tomography (SPECT). There are growing evidences underlying a possible correlation between these two conditions; in this report we describe a patient affected by retinitis pigmentosa with a positive [123I]Ioflupane scan underlying a possible connection with Parkinson's disease. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15069680
- Volume :
- 26
- Database :
- Complementary Index
- Journal :
- Nuclear Medicine Review
- Publication Type :
- Academic Journal
- Accession number :
- 164665572
- Full Text :
- https://doi.org/10.5603/NMR.a2022.0040